Prevention PQS 2022/23

The Organisation Data Service (ODS) code of the premises at which pharmaceutical services may be provided

The name under which a pharmacy contractor, appliance contractor, or local pharmaceutical services contractor trades

The name under which a pharmacy contractor, appliance contractor, or local pharmaceutical services contractor trades

The unique code used to refer to an ICB

Do you declare that by the end of 31 March 2023 you will have completed the TARGET treating your infections review? Answers: yes / no Mandatory

Do you declare that where concerns are identified when completing the TARGET treating your infections review, the patient's GP will be promptly notified? Answers: yes / no Mandatory

Do you declare that by the end of 31 March 2023 you will have shared your anonymised audit data or declared that no patients have been identified as being suitable for review via the data collection tool on the NHSBSA MYS application? Answers: yes / no Mandatory

Between 1 April 2020 and the end of 31 March 2023, will all non-registered pharmacy staff working at the pharmacy on the day of the declaration have satisfactorily completed the infection prevention and control Level 1 e-learning and assessment on the e-Learning for Healthcare website? Answers: yes / no Mandatory

Between 1 April 2020 and the end of 31 March 2023, will all registered pharmacy professionals working at the pharmacy on the day of the declaration have satisfactorily completed the HEE infection prevention and control Level 2 e-learning and assessment? Answers: yes / no Mandatory

Between 1 April 2020 and the end of 31 March 2023, will all patient-facing pharmacy staff working at the pharmacy on the day of declaration have satisfactorily completed the Antimicrobial Stewardship for Community Pharmacy e-learning and e-assessment? Answers: yes / no Mandatory

By the end of 31 March 2023, will all patient-facing staff working at the pharmacy on the day of the declaration and who provide health advice have become Antibiotic Guardians and have an awareness of the local antibiotic formulary? Answers: yes / no Mandatory

By the end of 31 March 2023, do you declare that you will have, at premises level, a new or updated AMS action plan on how you would promote AMS in your day-to-day practice, which will be available for inspection on the premises? Answers: yes / no Mandatory

By the end of 31 March 2023, will all patient-facing staff working at the pharmacy on the day of declaration, who provide advice on medicines or healthcare, have completed Module 1 of the Let''s Communicate Cancer (BOPA) and completed the associated quiz which is available on the elfh website, or have completed the BOPA Let''s Communicate Cancer Series on the BOPA website since 31 March 2021 and have the certificate of completion? Answers: yes / no Mandatory

Do you declare that, by the end of 31 March 2023, the pharmacy will have available, at premises level, a new risk review undertaken as part of the PQS 2022/23 which includes the management plans to minimise the risk of missing suspected cancer symptoms? Answers: yes / no Mandatory

Can you evidence that you have a process in place to identify red flag signs and symptoms that could be suspected cancer symptoms and refer these patients to their GP? Answers: yes / no Mandatory

By the day of declaration, how many patients were referred to their GP following detection of red flag signs and symptoms that could be suspected cancer symptoms? Answers: 0 - 100 (capped at 100) Mandatory